All Publications

Pages

1. • Speech

   • 

   Renal Insufficiency in Cancer Patients : Results of the Birma Study

   Wildiers, Hans Janus, N. Byloos, E.[UCL] Machiels, Jean-Pascal[UCL] Duck, Lionel KERGER, Joseph[UCL] Wynendaele, W. Canon, J. Lybaert, W. Launay-Vacher, V. (2008) 33rd European-Society-for-Medical-Oncology Congress — (Sweden) Stockholm
2. • Speech

   • 

   Retrospective analysis of cardiac safety in EBC women treated with the chemotherapy regimen: FEC followed by docetaxel plus trastuzumab

   Jacquemin, L.[UCL] Duck, Lionel Berlière, Martine[UCL] Machiels, Jean-Pascal[UCL] Mazzeo, Filomena[UCL] Whenham, N. Hammouch, Fatima[UCL] Baurain, Jean-François[UCL] (2010) European Breast Cancer Conference — (Spain) Barcelona
3. • Speech

   • 

   A phase I study of sorafenib in association with docetaxel-prednisone in chemonaive metastatic castration-resistant prostate cancer : Abstrac #5153

   Mardjuadi, Feby[UCL] Medioni, J. Kerger, Joseph Canon, J. L. Duck, Lionel Oudard, S. Clausse, M. D'HONDT, Lionel Moxhon, A. Machiels, Jean-Pascal[UCL] (2009) 45th Annual Meeting of the American-Society-of-Clinical-Oncology — (United-States) Orlando, Florida
4. • Speech

   • 

   Sunitinib plus docetaxel and trastuzumab as first-line therapy for HER2+advanced breast cancer

   Cardoso, F. Canon, J. L. Amadori, D. Dirix, L. Villa, E. Aldrighetti, D. Machiels, Jean-Pascal[UCL] Verkh, L. Kern, K. Giorgetti, C. (2009) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology — Berlin(Germany)
5. • Speech

   • 

   An International Expanded Access Program (EAP) of RAD001 (everolimus) in patients with metastatic renal cell carcinoma (mRCC) who fail, or become intolerant of a prior vascular endothelial growth factor receptor (VEGFr) therapy

   Grünwald, V. Rah, S.Y. Miller, K. Karakiewicz, P.I. Machiels, Jean-Pascal[UCL] Hajdenberg, J.J. Rini, B.I. Rosamilia, M. Resta, D. Lee, S.H. (2009) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology — Berlin(Germany)
6. • Speech

   • 

   Chemoresistance in hematopoietic cells by retroviral gene transfer of the multidrug resistance-associated protein (MRP) cDNA

   D'Hondt, Véronique[UCL] Machiels, Jean-Pascal[UCL] Caruso, M. Bank, A. Symann, Michel[UCL] (1997) 26th Annual Meeting og the International Society for Experimental Hematology — (France) Cannes
7. • Speech

   • 

   Planned neck dissection after chemoradiation for advanced head and neck cancer. : Is it always indicated?

   Hamoir, Marc[UCL] Schmitz, Sandra[UCL] Lonneux, Max[UCL] Weynand, Birgit[UCL] Machiels, Jean-Pascal[UCL] Grégoire, Vincent[UCL] (2007) 14th European Cancer Conference (ECCO 14) — (Spain) Barcelona
8. • Speech

   • 

   A dose escalating study of cabazitaxel (XRP6258) in combination with capecitabine, in patients (pts) with metastatic breast cancer (MBC) progressing after anthracycline and taxane therapy

   Villanueva, C. Awada, A. Campone, M. Machiels, Jean-Pascal[UCL] Besse, T. Magherini, E. Dubin, F. Semiond, D. Pivot, X. (2009) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology — Berlin(Germany)
9. • Journal article

   • 

   Phase II study of sunitinib in recurrent or metastatic squamous cell carcinoma of the head and neck: GORTEC 2006-01

   Machiels, Jean-Pascal[UCL] Henry S[UCL] Zanetta, S[UCL] Kaminsky, M[UCL] Michoux, Nicolas[UCL] Rommel, Denis[UCL] Duprez, Thierry[UCL] (2010) Journal of clinical oncology — Vol. 28, no. 1, p. 21-28 (January 2010)
10. • Speech

    • 

    Safety, molecular and imaging responses to cetuximab administered in a window pre-operative study in squamous cell carcinoma of the head and neck(SCCHN)

    Schmitz, Sandra[UCL] Hamoir, Marc[UCL] Reychler, Hervé[UCL] Magremanne, Michèle[UCL] Weynand, Birgit[UCL] Lhommel, Renaud[UCL] Hanin, François-Xavier[UCL] Lonneux, Max[UCL] Rommel, Denis[UCL] Michoux, Nicolas[UCL] Duprez, Thierry[UCL] Machiels, Jean-Pascal[UCL] (2012) ASCO Annual Meeting — Chicago, Illinois
11. • Speech

    • 

    Abstract P5-03-03: Tumor sequencing is useful to reclassify germline variants in unexplained high-risk breast cancer families

    van Marcke, Cédric[UCL] Helaers, Raphaël[UCL] Schoonjans, Céline[UCL] Berliere, Martine[UCL] De Leener, Anne[UCL] Canon, Jean-Luc Vuylsteke, Peter Machiels, Jean-Pascal[UCL] Limaye, Nisha[UCL] Vikkula, Miikka[UCL] Duhoux, Francois[UCL] (2020) Abstracts: 2019 San Antonio Breast Cancer Symposium; December 10-14, 2019; San Antonio, Texas — San Antonio, Texas
12. • Journal article

    • 

    Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study

    Siefker-Radtke, Arlene O Necchi, Andrea Park, Se Hoon García-Donas, Jesús Huddart, Robert A Burgess, Earle F Fleming, Mark T Rezazadeh Kalebasty, Arash Mellado, Begoña Varlamov, Sergei Joshi, Monika Duran, Ignacio Tagawa, Scott T Zakharia, Yousef Akapame, Sydney Santiago-Walker, Ademi E Monga, Manish O'Hagan, Anne Loriot, Yohann BLC2001 Study Group Machiels, Jean-Pascal[UCL] (2022) The Lancet. Oncology — Vol. 23, no. 2, p. 248-258 (2022)
13. • Journal article

    • 

    Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.

    van Marcke, Cédric[UCL] Honoré, Natasha[UCL] van der Elst, Athénaïs[UCL] Beyaert, Simon[UCL] Derouane, Françoise[UCL] Dumont, Caroline[UCL] Aboubakar Nana, Frank[UCL] Baurain, Jean-François[UCL] Borbath, Ivan[UCL] Collard, Philippe[UCL] Cornelis, Frank[UCL] De Cuyper, Astrid[UCL] Duhoux, Francois[UCL] Filleul, Bertrand Galot, Rachel[UCL] Gizzi, Marco[UCL] Mazzeo, Filomena[UCL] Pieters, Thierry[UCL] Seront, Emmanuel[UCL] Sinapi, Isabelle[UCL] Van Den Eynde, Marc[UCL] Whenham, Nicolas Yombi, Jean Cyr[UCL] Scohy, Anaïs[UCL] van Maanen, Aline[UCL] Machiels, Jean-Pascal[UCL] (2021) BMC cancer — Vol. 21, no.1, p. 578 [1-12] (2021)
14. • Journal article

    • 

    Multidisciplinary quality assurance and control in oncological trials: Perspectives from European Organisation for Research and Treatment of Cancer (EORTC).

    Members of EORTC QAC Working Groups of Scientific Experts Machiels, Jean-Pascal[UCL] (2017) European Journal of Cancer — Vol. 86, p. 91-100 (2017)
15. • Journal article

    • 

    Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.

    El Baroudi, Mariama[UCL] Machiels, Jean-Pascal[UCL] Schmitz, Sandra[UCL] (2017) Cancer Biology & Therapy — Vol. 18, no.10, p. 775-782 (2017)
16. • Journal article

    • 

    Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?

    Van Praet, Charles Rottey, Sylvie Van Hende, Fransien Pelgrims, Gino Demey, Wim Van Aelst, Filip Wynendaele, Wim Gil, Thierry Schatteman, Peter Filleul, Bertrand Schallier, Denis Machiels, Jean-Pascal[UCL] Schrijvers, Dirk Everaert, Els D'Hondt, Lionel Werbrouck, Patrick Vermeij, Joanna Mebis, Jeroen Clausse, Marylene Rasschaert, Marika Van Erps, Joanna Verheezen, Jolanda Van Haverbeke, Jan Goeminne, Jean-Charles Lumen, Nicolaas (2017) Clinical Genitourinary Cancer — Vol. 15, no. 4, p. 502-508 (2017)
17. • Journal article

    • 

    PPARα-mediated fatty acid metabolism reprogramming supports resistance to anti-EGFR targeted therapy in head and neck squamous cell carcinoma

    Van den Bossche, Valentin[UCL] Vignau, Julie[UCL] Vigneron, Engy[UCL] Zaryouh, Hannah Wouters, An Ambroise, Jérôme[UCL] Van Laere, Steven Mignion, Lionel[UCL] Lepicard, Elise[UCL] Jordan, Bénédicte[UCL] Guilbaud, Céline[UCL] Dahou, Hajar[UCL] Mendola, Antonella[UCL] Desgres, Manon[UCL] Aubert, Léo[UCL] Gerin, Isabelle[UCL] Bommer, Guido[UCL] Boidot, Romain Vermonden, Perrine[UCL] Warnant, Aurélien[UCL] Larondelle, Yvan[UCL] Machiels, Jean-Pascal[UCL] Feron, Olivier[UCL] Schmitz, Sandra[UCL] Corbet, Cyril[UCL] (2023) Nature Communications — (2023)
18. • Journal article

    • 

    Tumour-agnostic plasma assay for circulating tumour DNA predicts outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with a PD-1 inhibitor.

    Honoré, Natasha[UCL] van der Elst, Athénaïs[UCL] Dietz, Anna van Marcke, Cédric[UCL] Helaers, Raphael Mendola, Antonella[UCL] Dahou, Hajar Marbaix, Etienne Poncin, Renaud Seront, Emanuel Schmitz, Sandra[UCL] Limaye, Nisha[UCL] Galot, Rachel[UCL] Machiels, Jean-Pascal[UCL] (2023) European journal of cancer (Oxford, England : 1990) — Vol. 195, no.a, p. 113372 (2023)
19. • Journal article

    • 

    Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck

    Honoré, Natasha[UCL] van Marcke, Cédric[UCL] Galot, Rachel[UCL] Helaers, Raphaël[UCL] Van Maanen, Aline[UCL] Ambroise, Jérôme[UCL] Mendola, Antonella[UCL] Dahou, Hajar[UCL] Marbaix, Etienne[UCL] van Eeckhout, Pascal Longton, Eleonore Magremanne, Michele Schmitz, Sandra[UCL] Limaye, Nisha[UCL] Machiels, Jean-Pascal[UCL] (2023) Annals of Oncology — (2023)
20. • Speech

    • 

    Minimal residual disease (MRD) diagnosed by a plasma tumor-agnostic circulating tumor DNA (ctDNA) assay after curative therapy in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) predicts disease relapse and survival

    Honoré, Natasha[UCL] van Marcke, Cédric[UCL] Galot, Rachel[UCL] Helaers, Raphaël[UCL] Van Maanen, Aline[UCL] Ambroise, Jérôme[UCL] Mendola, Antonella[UCL] Dahou, Hajar[UCL] Marbaix, Etienne[UCL] Van Eeckhout, Pascal[UCL] longton, Eléonore[UCL] Magremanne, Michèle[UCL] Schmitz, Sandra[UCL] Limaye, Nisha[UCL] Machiels, Jean-Pascal[UCL] (2023) ESMO Congress 2023 — Madrid
21. • Journal article

    • 

    Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib

    Awada, Ahmad Berghmans, Thierry Clement, Paul M. Cuppens, Kristof De Wilde, Bram Machiels, Jean-Pascal[UCL] Pauwels, Patrick Peeters, Marc Rottey, Sylvie Van Cutsem, Eric (2022) Critical reviews in oncology/hematology — Vol. 169, p. 103564 [11-8] (2022)
22. • Journal article

    • 

    Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial

    Gravis, Gwenaelle Fizazi, Karim Joly, Florence Oudard, Stéphane Priou, Franck Esterni, Benjamin Latorzeff, Igor Delva, Remy Krakowski, Ivan Laguerre, Brigitte Rolland, Fréderic Théodore, Christine Deplanque, Gael Ferrero, Jean Marc Pouessel, Damien Mourey, Loïc Beuzeboc, Philippe Zanetta, Sylvie Habibian, Muriel Berdah, Jean François Dauba, Jerome Baciuchka, Marjorie Platini, Christian Linassier, Claude Labourey, Jean Luc Machiels, Jean-Pascal[UCL] El Kouri, Claude Ravaud, Alain Suc, Etienne Eymard, Jean Christophe Hasbini, Ali Bousquet, Guilhem Soulie, Michel (2013) The Lancet Oncology — Vol. 14, no.2, p. 149-158 (2013)
23. • Speech

    • 

    An Exploratory Study of Sunitinib (SU) Plus Docetaxel (D) and Trastuzumab (T) for First-Line Therapy of HER2+Advanced Breast Cancer (ABC).

    Dirix, L. Machiels, Jean-Pascal[UCL] Canon, Jean-Luc Amadori, D. Villa, E. Aldrighetti, D. Verkh, L. Bouko, Y. Kem, K. Giorgetti, C. Cardoso, F. (2009) 32nd Annual San Antonio Breast Cancer Symposium — (United-States) San Antonio, Texas
24. • Journal article

    • 

    Management and palliative chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck

    Machiels, Jean-Pascal[UCL] Schmitz, Sandra[UCL] (2011) Expert Review of Anticancer Therapy — Vol. 11, no. 3, p. 359-371 (2011)
25. • Journal article

    • 

    A randomized, double-blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxel

    Maison-Blanche, Pierre Vermorken, Jan B Goksel, Tuncay Machiels, Jean-Pascal[UCL] Agarwala, Sanjiv Rottey, Sylvie Daugaard, Gedske Volovat, Constantin Scheulen, Max Sengeløv, Lisa Grecea, Dana Eniu, Alexandru Jäger, Elke Meiri, Eyal Cascinu, Stefano Strumberg, Dirk Demir, Gokhan Clemens, Michael Pinotti, Graziella Nardi, Mario Guthrie, Troy Boelle, Emmanuelle Magherini, Emmanuelle (2013) Journal of Cardiovascular Pharmacology — Vol. 61, no.6, p. 495-504 (2013)

Pages